U.S. Markets open in 3 hrs 42 mins

Why Canada Goose (GOOS) Could Be an Impressive Growth Stock

Zacks Equity Research

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.

One such company that might be well-positioned for future earnings growth is Canada Goose Holdings Inc. GOOS. This firm, which is in the Retail - Apparel and Shoes industry, saw a significant EPS growth last year, and is looking great for this year too.

In fact, the current growth estimate for this year calls for earnings-per-share growth of 46.1%. Furthermore, the long-term growth rate is currently an impressive 31.3%, suggesting pretty good prospects for the long haul.

Canada Goose Holdings Inc. Price and Consensus

Canada Goose Holdings Inc. Price and Consensus

Canada Goose Holdings Inc. price-consensus-chart | Canada Goose Holdings Inc. Quote

And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 2.1%. Thanks to this rise in earnings estimates, GOOS has a Zacks Rank #1 (Strong Buy) which further underscores the potential for outperformance in this company. You can see the complete list of today’s Zacks #1 Rank stocks here.

So, if you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider GOOS. Not only does it have double-digit earnings growth prospects, but its impressive Zacks Rank suggests that analysts believe better days are ahead for GOOS as well.  

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Canada Goose Holdings Inc. (GOOS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.